ASLAN Pharmaceuticals Limited (ASLN)

Etorro trading 970x250
ASLAN Pharmaceuticals Limited (ASLN) Logo

About ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited, a clinical-stage immunology and oncology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company’s clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and a small molecule inhibitor targeting oncology. Its partners include Almirall, Array BioPharma, Bristol-Myers Squibb, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore. Address: 83 Clemenceau Avenue, Singapore, Singapore, 239920

ASLAN Pharmaceuticals Limited News and around…

Latest news about ASLAN Pharmaceuticals Limited (ASLN) common stock and company :

ASLAN Pharmaceuticals Announces Participation at Two Upcoming Virtual Investor Conferences
22 Nov, 2021 Yahoo! Finance

MENLO PARK, Calif. and SINGAPORE, Nov. 22, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that Dr Carl Firth, CEO, will be participating in fireside chats at two upcoming virtual health conferences. The details are as follows: Piper Sandler 33rd Annual Virtual Healthcare Conference Recorded discussion available: November 22, 2021, at

10 Top Penny Stocks To Watch With Potential Biotech Catalysts This Week
14 Nov, 2021 FinancialContent
ASLAN Pharmaceuticals to Participate in Fireside Chat at the 12th Annual Jefferies London Healthcare Conference 2021
10 Nov, 2021 Yahoo! Finance

MENLO PARK, Calif. and SINGAPORE, Nov. 10, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced Dr Carl Firth, CEO, will participate in-person at the 12th Annual Jefferies London Healthcare Conference on November 17, 2021, at 1:00pm GMT. The conference will be held in-person November 16 and 17, 2021 and virtually November 18 and 19, 2021. A l

ASLAN Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
26 Oct, 2021 Yahoo! Finance

ASLAN004 met primary endpoint and key secondary efficacy endpoints in a Phase 1 Multiple-Ascending-Dose (MAD) trial in patients with moderate-to-severe atopic dermatitis (AD) On track to initiate Phase 2b 300-patient clinical trial for ASLAN004 in 4Q 2021 Company maintains strong operating position and cash runway through late 2023Replay available for company-hosted KOL event on AD landscape and to recap Phase 1 MAD data MENLO PARK, Calif. and SINGAPORE, Oct. 26, 2021 (GLOBE NEWSWIRE) -- ASLAN P

ASLAN Pharmaceuticals Announces Scientific Collaboration With Dr Emma Guttman-Yassky on Identification of ASLAN004-Specific Biomarkers
22 Oct, 2021 Yahoo! Finance

MENLO PARK, Calif. and SINGAPORE, Oct. 22, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced a collaboration with renowned inflammatory skin disease expert Dr Emma Guttman-Yassky, MD PhD, to conduct research that will continue throughout ASLAN’s Phase 2b program to identify and characterize the effects of ASLAN004 on disease-associated s

ASLAN Pharmaceuticals Announces KOL Event Series to Discuss Atopic Dermatitis Treatment Landscape and ASLAN004
18 Oct, 2021 Yahoo! Finance

- Management to host the first in a series of KOL webinars beginning Monday, October 25, 2021, at 10:00am ET - First patient in global, 300-patient Phase 2b study of ASLAN004 on track for enrolment in 4Q 2021 MENLO PARK, Calif. and SINGAPORE, Oct. 18, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced it will host the first in a series of

First Week of ASLN December 17th Options Trading
15 Oct, 2021 FinancialContent

Investors in ASLAN Pharmaceuticals Ltd (ASLN) saw new options begin trading this week, for the December 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ASLN options chain for the new December 17th contracts and identified the following call contract of particular interest.

ASLAN Pharmaceuticals Announces Expansion of Scientific Advisory Board With Appointment of Leading Global Experts in Dermatology and Immunology
14 Oct, 2021 Yahoo! Finance

MENLO PARK, Calif. and SINGAPORE, Oct. 14, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the appointments of Dr Melinda Jennifer Gooderham, MSc MD FRCPC, Dr Jacob Thyssen, MD PhD DmSci, and Associate Professor Peter Foley, BMedSci MBBS MD FACD, as members of its Scientific Advisory Board (SAB). The SAB, chaired by Dr Lawrence Eichenf

12 Health Care Stocks Moving In Thursday's After-Market Session
30 Sep, 2021 FinancialContent

Gainers FibroGen (NASDAQ:FGEN) stock moved upwards by 4.99% to $10.73 during Thursday's after-market session. The company's market ...

50 Biggest Movers From Yesterday
28 Sep, 2021 FinancialContent

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares surged 50% to close at $3.60 on Monday after the company said its subsidiary, ...

Mid-Afternoon Market Update: Dow Gains 150 Points; Red Cat Holdings Shares Spike Higher
27 Sep, 2021 FinancialContent

Toward the end of trading Monday, the Dow traded up 0.43% to 34,949.08 while the NASDAQ fell 0.35% to 14,995.27. The S&P also fell, ...

12 Health Care Stocks Moving In Monday's Intraday Session
27 Sep, 2021 FinancialContent

Gainers Keros Therapeutics (NASDAQ:KROS) stock moved upwards by 26.51% to $41.75 during Monday's regular session. ...

Mid-Day Market Update: Crude Oil Rises 2%; ASLAN Pharmaceuticals Shares Slide
27 Sep, 2021 FinancialContent

Midway through trading Monday, the Dow traded up 0.70% to 35,041.74 while the NASDAQ fell 0.51% to 14,970.85. The S&P also rose, ...

31 Stocks Moving In Monday's Mid-Day Session
27 Sep, 2021 FinancialContent

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 54.1% to $3.6998 after the company said its subsidiary, Skypersonic, ...

Mid-Morning Market Update: Markets Mixed; US Durable Goods Orders Increase Sharply In August
27 Sep, 2021 FinancialContent

Following the market opening Monday, the Dow traded up 0.65% to 35,024.73 while the NASDAQ fell 0.98% to 14,899.77. The S&P also ...

12 Health Care Stocks Moving In Monday's Pre-Market Session
27 Sep, 2021 FinancialContent

Gainers Syndax Pharmaceuticals (NASDAQ:SNDX) shares moved upwards by 8.94% to $20.48 during Monday's pre-market ...

Why Did ASLAN Pharma Shares Plunge Despite Positive Atopic Dermatitis Trial Data?
27 Sep, 2021 FinancialContent

ASLAN Pharmaceuticals Ltd(NASDAQ:ASLN) hasannounced topline datafrom its Phase 1 study of ASLAN004 for ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
27 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, investor! We're starting off the week with a dive into the biggest pre-market stock movers for Monday morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

20 Stocks Moving in Monday's Pre-Market Session
27 Sep, 2021 FinancialContent

Gainers Puhui Wealth Investment Management Co., Ltd. (NASDAQ: PHCF) rose 49% to $3.65 in pre-market trading. Paltalk, Inc. ...

ASLAN Pharmaceuticals Announces Positive Data Conclusively Establishing Proof of Concept for ASLAN004 in Atopic Dermatitis
27 Sep, 2021 FinancialContent
10 Top Penny Stocks To Watch This Week With Potential Biotech Catalysts
26 Sep, 2021 FinancialContent
ASLAN Pharmaceuticals to Participate in the 2021 Cantor Virtual Global Healthcare Conference
22 Sep, 2021 FinancialContent
ASLAN Pharmaceuticals Establishes Scientific Advisory Board Chaired by Distinguished Dermatology Expert Dr Lawrence Eichenfield
21 Sep, 2021 FinancialContent
ASLAN Pharmaceuticals Establishes Scientific Advisory Board Chaired by Distinguished Dermatology Expert Dr Lawrence Eichenfield
21 Sep, 2021 Yahoo! Finance

MENLO PARK. Calif. and SINGAPORE, Sept. 21, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the appointment of Dr Lawrence Eichenfield, MD, FAAD, as chair of its Scientific Advisory Board, comprising experts in dermatology and allergic disease from the United States, Canada, Europe, and Asia. Dr Eric Simpson, MD, MCR, was also appointe

Saniona appoints Robert Hoffman to Board of Directors as Chair of the Audit Committee
16 Sep, 2021 FinancialContent
Implied Volatility Surging for ASLAN Pharmaceuticals (ASLN) Stock Options
13 Sep, 2021 Yahoo! Finance

Investors need to pay close attention to ASLAN Pharmaceuticals (ASLN) stock based on the movements in the options market lately.

ASLAN Pharmaceuticals to Present at H.C. Wainwright 23rd Annual Global Investment Conference
09 Sep, 2021 FinancialContent
54 Biggest Movers From Yesterday
02 Sep, 2021 FinancialContent

Gainers Focus Universal Inc. (NASDAQ: FCUV) shares climbed 278% to close at $19.28 on Wednesday. The stock started trading on ...

Interesting ASLN Call Options For April 2022
23 Aug, 2021 FinancialContent

Investors in ASLAN Pharmaceuticals Ltd (ASLN) saw new options begin trading this week, for the April 2022 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 234 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

ASLAN Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
06 Aug, 2021 FinancialContent

ASLAN Pharmaceuticals Limited (ASLN) is a NASDAQ Common Stock listed in , ,

970x250